Back to Journals

OncoTargets and Therapy


Aims and Scope

Editor-in-Chief: Dr Faris Farassati

OncoTargets and Therapy is an international, peer-reviewed journal focusing on molecular aspects of cancer research, that is, the molecular diagnosis of and targeted molecular or precision therapy for all types of cancer. Topics include: early stage clinical trials, detailed case reports dealing with molecular pathology, novel therapeutic regimens for improved benefit and/or decreased side effects, description of novel therapeutic targets and innovative agents. This journal explores the evidence behind new and existing therapies to aid their informed acceptance by clinicians and treatment adherence by patients.

Tissue microarray analyses will not be considered except in cases where they are supported by comprehensive biological studies involving multiple cell lines. Likewise, biomarker association studies will only be considered when validated by comprehensive in vitro data and analysis of human tissue samples. Studies containing in vivo animal model data will be considered favorably.

All meta-analyses must be submitted with a completed 27-point checklist to indicate adherence to the PRISMA guidelines for reporting systematic reviews and meta-analyses (http://prisma-statement.org/)